American Century Companies’s Praxis Precision Medicines PRAX Stock Holding History

American Century Companies's PRAX Position: Q2 2026 in Review

American Century Companies increased its Praxis Precision Medicines (PRAX) stake by 85% in Q2 2026, buying an estimated $34.5M and bringing the position to 237,315 shares worth $79.5M. The position accounts for 0.04% of the portfolio, ranked #624.

American Century Companies first reported a position in PRAX in Q1 2024 and has held it in 7 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

• American Century Companies held 237,315 shares of Praxis Precision Medicines worth $79.5M as of Q2 2026.
• American Century Companies bought 109,061 Praxis Precision Medicines shares in Q2 2026, an estimated $34.5M.
• Praxis Precision Medicines made up 0.04% of American Century Companies's portfolio in Q2 2026, its #624 holding.
• American Century Companies first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 7 quarters since.
• 309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.